Study Description
The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis suppurativa (HS). The total duration of the study is 76 weeks and consists of: Screening (up to 4 weeks), Treatment Period 1 (16 weeks, double-blind treatment with remibrutinib (Dose A or Dose B) or placebo, Treatment Period 2 (52 weeks, treatment with remibrutinib (Dose A or Dose B) and Safety Follow-Up (treatment-free follow-up for 4 weeks).
Participants who prematurely discontinue study treatment (either during Treatment Period 1 or Treatment Period 2) are encouraged to remain in the study. Participants who do not wish to remain in the study will enter a 4-week Safety Follow-Up period.
Interventions
Placebo 1
Placebo 2
Remibrutinib Dose A
Remibrutinib Dose B
Eligibility Criteria
Key Inclusion Criteria:
1. Male and female participants ≥ 18 years of age at the time of signing of the informed consent.
2. Diagnosis of HS based on clinical history and physical examination for at least 6 months prior to the Baseline visit.
3. Participants with moderate to severe HS defined as:
* A total of at least 5 AN count (abscesses and/or inflammatory nodules) AND
* Inflammatory lesions should affect at least 2 distinct anatomic areas (e.g., left and right axillae)
Key Exclusion Criteria:
1. Presence of more than 20 fistulae/tunnels (both draining and non-draining) in total at baseline.
2. Any active skin disease or conditions that may interfere with the assessment of HS.
3. Previous exposure to remibrutinib or other BTK inhibitors.
4. Use of other investigational drugs within 5 half-lives of enrollment, or within 30 days (for small molecules) prior to randomization, or until the pharmacodynamic effect has returned to baseline (for biologics), whichever is longer.
5. Significant bleeding risk or coagulation disorders.
6. History of gastrointestinal bleeding.
7. Requirement for anti-platelet (except for acetylsalicylic acid up to 100 mg/d or clopidogrel up to 75 mg/d) or anti-coagulant medication.
8. History or current hepatic disease.
9. Evidence of clinically significant cardiovascular, neurological, psychiatric, pulmonary, renal, hepatic, endocrine, metabolic, hematological disorders, gastrointestinal disease or immunodeficiency that, in the Investigator's opinion, would compromise the safety of the participant, interfere with the interpretation of the study results or otherwise preclude participation or protocol adherence of the participant.
10. History of hypersensitivity to any of the study drug constituents.
11. Known or suspected infectious disease that is active, chronic or recurrent which precludes the participant from participating in the trial as per investigator's assessment. These infectious diseases include and are not limited to opportunistic infections (e.g., tuberculosis, atypical mycobacterioses, listeriosis or aspergillosis) and/or known or suspected Human Immunodeficiency Virus (HIV) infection. Should it be required by local regulations and/or considered appropriate by the investigator, an HIV test can be performed to confirm eligibility.
12. History of live attenuated vaccine administration within 6 weeks prior to randomization or requirement to receive these vaccinations at any time while on study treatment.
13. Major surgery within 8 weeks prior to screening or planned surgery for the duration of the study.
Other protocol-defined inclusion/exclusion criteria may apply.
Novartis Investigative Site
Recruiting
Caba,Buenos Aires,C1425bea,Argentina
Novartis Investigative Site
Recruiting
Ciudad Autonoma de Bs As,C1428azf,Argentina
Novartis Investigative Site
Recruiting
Santa Fe,Rosario,S2000dbs,Argentina
Novartis Investigative Site
Recruiting
Ciudad Autonoma de Bs As,Buenos Aires,C1119acn,Argentina
Novartis Investigative Site
Recruiting
Darlinghurst,2010,Australia
Novartis Investigative Site
Recruiting
Melbourne,Victoria,3004,Australia
Novartis Investigative Site
Recruiting
Phillip,Australian Capital Territory,2606,Australia
Novartis Investigative Site
Recruiting
Westmead,New South Wales,2145,Australia
Novartis Investigative Site
Recruiting
Parkville,Victoria,3050,Australia
Novartis Investigative Site
Recruiting
Stara Zagora,6000,Bulgaria
Novartis Investigative Site
Recruiting
Pleven,5800,Bulgaria
Novartis Investigative Site
Recruiting
Sofia,1407,Bulgaria
Novartis Investigative Site
Recruiting
Surrey,British Columbia,V3v 0c6,Canada
Novartis Investigative Site
Recruiting
St Johns,Newfoundland and Labrador,A1e 1v4,Canada
Novartis Investigative Site
Recruiting
Hamilton,Ontario,L8l 3c3,Canada
Novartis Investigative Site
Recruiting
Richmond Hill,Ontario,L4c 9m7,Canada
Novartis Investigative Site
Recruiting
Quebec,G1w 4r4,Canada
Novartis Investigative Site
Recruiting
Beijing,100043,China
Novartis Investigative Site
Recruiting
Kobenhavn N V,2400,Denmark
Novartis Investigative Site
Recruiting
Roskilde,4000,Denmark
Novartis Investigative Site
Recruiting
Kiel,24105,Germany
Novartis Investigative Site
Recruiting
Langenau,Baden-Wuerttemberg,89129,Germany
Novartis Investigative Site
Recruiting
Mainz,55131,Germany
Novartis Investigative Site
Recruiting
Darmstadt,Hessen,64283,Germany
Novartis Investigative Site
Recruiting
Muenster,48149,Germany
Novartis Investigative Site
Recruiting
Dresden,01307,Germany
Novartis Investigative Site
Recruiting
Halle Saale,Sachsen-Anhalt,06108,Germany
Novartis Investigative Site
Recruiting
Berlin,10789,Germany
Novartis Investigative Site
Recruiting
Berlin,13353,Germany
Novartis Investigative Site
Recruiting
Bochum,44791,Germany
Novartis Investigative Site
Recruiting
Heraklion Crete,71110,Greece
Novartis Investigative Site
Recruiting
Firenze,FI,50122,Italy
Novartis Investigative Site
Recruiting
Roma,RM,00168,Italy
Novartis Investigative Site
Recruiting
Kuala Lumpur,59100,Malaysia
Novartis Investigative Site
Recruiting
Muar,Johor,84000,Malaysia
Novartis Investigative Site
Recruiting
Kota Bharu,Kelantan,15586,Malaysia
Novartis Investigative Site
Recruiting
Kuching,Sarawak,93586,Malaysia
Novartis Investigative Site
Recruiting
Kuala Terengganu,Terengganu,20400,Malaysia
Novartis Investigative Site
Recruiting
Pulau Pinang,10990,Malaysia
Novartis Investigative Site
Recruiting
Gdansk,80-214,Poland
Novartis Investigative Site
Recruiting
Lodz,90-436,Poland
Novartis Investigative Site
Recruiting
Bydgoszcz,85-094,Poland
Novartis Investigative Site
Recruiting
Bratislava,81109,Slovakia
Novartis Investigative Site
Recruiting
Presov,08001,Slovakia
Novartis Investigative Site
Recruiting
Raslouw Centurion,Gauteng,0157,South Africa
Novartis Investigative Site
Recruiting
Valencia,Comunidad Valenciana,46017,Spain
Novartis Investigative Site
Recruiting
Barcelona,Catalunya,08003,Spain
Novartis Investigative Site
Recruiting
Madrid,28009,Spain
Novartis Investigative Site
Recruiting
Madrid,28046,Spain
Novartis Investigative Site
Recruiting
Cadiz,Andalucia,11009,Spain
Essential Medical Research
Recruiting
Tulsa,Oklahoma,74137,United States
Melissa Morgan
Florida Academic Centers Research and Education LLC
Recruiting
Coral Gables,Florida,33134,United States
Francisco A Kerdel
Illinois Dermatology Institute
Recruiting
Chicago,Illinois,60602,United States
G Michael Lewitt
Hayden Brotz
Advanced Research Experts
Recruiting
Nashville,Tennessee,37211,United States
Mikaela Villagran
Adrian Rodriguez
Arkansas Research Trials
Recruiting
North Little Rock,Arkansas,72117,United States
Scott Michael Dinehart
UP Medical Center H System
Recruiting
Pittsburgh,Pennsylvania,15213-3403,United States
Joe Kuanheng Tung
Revival Research Institute
Recruiting
Troy,Michigan,48084,United States
Babaitha Sri Kasula
Ali Moiin
Physioseq
Recruiting
Sacramento,California,95826,United States
Lauren Downing
Stephanie Le
Michigan Center for Rsrch Company
Recruiting
Clarkston,Michigan,48346,United States
Wendy McFalda
Wake Forest Baptist Health
Recruiting
Winston-Salem,North Carolina,27104,United States
Rita Pichardo
Brittany Granger
Henry Ford Hospital
Recruiting
Detroit,Michigan,48202 2689,United States
Richard Huggins
Olive View UCLA Medical Center
Recruiting
Sylmar,California,91342,United States
Charlotte Jeong
April Armstrong
RFSA Dermatology
Recruiting
San Antonio,Texas,78213,United States
Janette Johnson
Lindsey Finklea
OnSite Clinical Solutions LLC
Recruiting
Huntersville,North Carolina,28078,United States
Nicole Seminara-Zambrzycka
Icahn School Of Med At Mount Sinai
Recruiting
New York,New York,10029,United States
Ahuva Cices
Jillian Gray
University of MiamiHealth System
Recruiting
Miami,Florida,33125,United States
Hadar Lev-Tov
Gwinnett Clinical Research Center
Recruiting
Snellville,Georgia,30078,United States
Jonathan S Weiss
Equity Medical LLC
Recruiting
Bowling Green,Kentucky,42104,United States
Erin Vincent
James Allred
Care Access Hoboken
Recruiting
Hoboken,New Jersey,07030,United States
Adolfo Obregon
Howard University College of Medicine
Recruiting
Washington,District of Columbia,20060,United States
Cheri Frey
Revival Research Institute LLC
Recruiting
Evans,Georgia,30809,United States
Ashkay Kumar
Frances Florentino
Johnson Dermatology
Recruiting
Fort Smith,Arkansas,72916,United States
Sandra Johnson
Virginia Clinical Research
Recruiting
Norfolk,Virginia,23507,United States
Crystal Temple
David M Pariser
Medical University of South Carolina MUSC
Recruiting
Charleston,South Carolina,29425,United States
Lara Wine Lee
Ziaderm Research LLC
Recruiting
North Miami Beach,Florida,33162,United States
Tory Sullivan
Unity Clinical Research
Recruiting
Oklahoma City,Oklahoma,73118,United States
Jarad Levin
Dawes Fretzin Clinical Rea Group
Recruiting
Indianapolis,Indiana,46256,United States
Kenneth Dawes
University of Mississippi Med Ctr
Recruiting
Jackson,Mississippi,39216,United States
Thy Huynh
Skinsearch of Rochester Inc
Recruiting
Rochester,New York,14623,United States
John H Tu
Clinical Trials Research Institute
Recruiting
Thousand Oaks,California,91320,United States
Navid Ezra
North Georgia Rheumatology Group
Recruiting
Lawrenceville,Georgia,30046,United States
Cynthia Lawrence Elliott
Cheryl Effron MD Inc
Recruiting
Anaheim,California,92807,United States
Cheryl Effron
Worldwide Contacts
If the location of your choosing does not feature any contact detail, please reach out using the information below.